Clinical Trials Browser

Unknown × Breast Neoplasms × 130-nm albumin-bound paclitaxel × Clear all

NCT04537286 2024-02-26

First-line Nab-paclitaxel Plus Cisplatin Plus Carilizumab in mTNBC Patients

Phase 2 Unknown

Breast Neoplasms

NCT04734262 2023-11-18

SPARK

Phase 2 Unknown

Breast Neoplasms, Triple Negative Breast Neoplasms

NCT03961698 2023-08-14

MARIO-3

Phase 2 Unknown

BreastGenitourinary

Breast Neoplasms, Carcinoma, Renal Cell, Triple Negative Breast Neoplasms

NCT05953909 2023-07-20

ERI-Based-01

Breast Neoplasms

NCT03907800 2022-10-27

NeoPATH

Phase 2 Unknown

Breast Neoplasms, Triple Negative Breast Neoplasms

NCT05491694 2022-08-08

HIFU

Phase 2 Unknown

Breast Neoplasms, Triple Negative Breast Neoplasms

NCT05444998 2022-07-06

Neoadjuvant Inituomab, Pyrrolidone and Nab-paclitaxel for HER2+Breast Cancer

Phase 2 Unknown

Breast Neoplasms

NCT04659499 2020-12-09

Nab-paclitaxel in Combination With Pyrotinib in Postoperative Adjuvant Therapy for HER2-positive Breast Cancer

Phase 2 Unknown

Breast Neoplasms

NCT04194684 2019-12-11

Nab-Paclitaxel in Patients With ER+/HER2- Recurrent Metastatic Breast Cancer

Phase 2 Unknown

Breast Neoplasms

NCT03959397 2019-05-22

Paclitaxel Injection (Albumin-bound) for Neoadjuvant Treatment of Breast Cancer

Phase 2 Unknown

Breast Neoplasms

NCT01830244 2017-07-02

Neonab

Phase 2 Unknown

Pathologic Complete Response, Breast Neoplasms

NCT00777673 2013-01-04

Preoperative Chemotherapy in Triple Negative Invasive Breast Cancer That Can be Removed by Surgery.

Phase 2 Unknown

Breast Neoplasms

NCT01625429 2012-11-09

Neoadjuvant Study of Nab-paclitaxel Plus Carboplatin in Breast Cancer

Phase 2 Unknown

Breast Neoplasms